date:Jan 15, 2013
e transparency initiative builds on a range of measures already undertaken by EFSA to increase understanding, strengthen scrutiny and build confidence in its work. These include a landmark opinion by its Scientific Committee on transparency in risk assessment and subsequent initiatives such as publishing the full list of scientific studies and previously unpublished data on aspartame during formulation of the Authoritys current draft opinion. EFSA has also opened up its Scientific Committee and